Babangida S Chori1,2, Benjamin Danladi2, Bassey A Inyang1, Michael P Okoh1, Maxwell M Nwegbu3, Adewale L Alli1, Augustine N Odili4. 1. Department of Medical Biochemistry, Faculty of Basic Medical Sciences, College of Health Sciences, University of Abuja, Abuja, Nigeria. 2. Circulatory Health Research Laboratory, Old Anatomy Block (Beside School of Nursing and Midwifery), University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria. 3. Department of Chemical Pathology, College of Health Sciences, Faculty of Basic Clinical Sciences, University of Abuja, Abuja, Nigeria. 4. Circulatory Health Research Laboratory, Old Anatomy Block (Beside School of Nursing and Midwifery), University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria. augustine.odili@uniabuja.edu.ng.
Abstract
BACKGROUND: Evidence linking homocysteine (Hcy) with cardiovascular diseases (CVD) or its risk factors are limited in a sub-Saharan black population. OBJECTIVE: We set out to evaluate the association between Hcy and hypertension and other CVD risk factors in a population of adult Nigerians. METHODS: Data of 156 adults aged 18-70 years was accessed from the North Central study site of the REmoving the MAsk on Hypertension (REMAH) study. Homocysteine, blood glucose and lipid profile in whole blood/serum were measured using standard laboratory methods. Hypertension was diagnosed if average of 5 consecutive blood pressure (BP) measurements obtained using a mercury sphygmomanometer was equal to or higher than 140 systolic and/or 90 mmHg diastolic or the individual is on antihypertensive medication. Hyperhomocysteinemia (HHcy) was defined as Hcy > 10 µmol/L. RESULTS: Of the 156 participants, 72 (43.5%) were hypertensive, of whom 18 had HHcy. Subjects with HHcy were significantly (p < 0.05) older (41.5 vs. 40.6yrs), had lower HDL-cholesterol (0.6 vs. 0.8 mmol/L) and higher systolic (145.5 vs. 126.0 mmHg) and diastolic BP (92.9 vs. 79.6 mmHg), compared to those without HHcy. Intake of alcohol and a 1 yr increase in age were respectively and significantly (p < 0.05) associated with a 1.54 and 0.10 µmol/L increase in Hcy. In a multivariable model adjusted for age, sex and body mass index, a 1 µmol/L increase in Hcy, was associated with a 1.69 mmHg and 1.34 mmHg increase in systolic and diastolic pressure (p < 0.0001) respectively; and a 0.01 mmol/L decrease in HDL-cholesterol (p < 0.05). CONCLUSION: HHcy occurs among hypertensive Nigerians and it is independently associated with age, HDL-cholesterol, systolic and diastolic BP.
BACKGROUND: Evidence linking homocysteine (Hcy) with cardiovascular diseases (CVD) or its risk factors are limited in a sub-Saharan black population. OBJECTIVE: We set out to evaluate the association between Hcy and hypertension and other CVD risk factors in a population of adult Nigerians. METHODS: Data of 156 adults aged 18-70 years was accessed from the North Central study site of the REmoving the MAsk on Hypertension (REMAH) study. Homocysteine, blood glucose and lipid profile in whole blood/serum were measured using standard laboratory methods. Hypertension was diagnosed if average of 5 consecutive blood pressure (BP) measurements obtained using a mercury sphygmomanometer was equal to or higher than 140 systolic and/or 90 mmHg diastolic or the individual is on antihypertensive medication. Hyperhomocysteinemia (HHcy) was defined as Hcy > 10 µmol/L. RESULTS: Of the 156 participants, 72 (43.5%) were hypertensive, of whom 18 had HHcy. Subjects with HHcy were significantly (p < 0.05) older (41.5 vs. 40.6yrs), had lower HDL-cholesterol (0.6 vs. 0.8 mmol/L) and higher systolic (145.5 vs. 126.0 mmHg) and diastolic BP (92.9 vs. 79.6 mmHg), compared to those without HHcy. Intake of alcohol and a 1 yr increase in age were respectively and significantly (p < 0.05) associated with a 1.54 and 0.10 µmol/L increase in Hcy. In a multivariable model adjusted for age, sex and body mass index, a 1 µmol/L increase in Hcy, was associated with a 1.69 mmHg and 1.34 mmHg increase in systolic and diastolic pressure (p < 0.0001) respectively; and a 0.01 mmol/L decrease in HDL-cholesterol (p < 0.05). CONCLUSION: HHcy occurs among hypertensive Nigerians and it is independently associated with age, HDL-cholesterol, systolic and diastolic BP.
Authors: Helga Refsum; Eha Nurk; A David Smith; Per M Ueland; Clara G Gjesdal; Ingvar Bjelland; Aage Tverdal; Grethe S Tell; Ottar Nygård; Stein E Vollset Journal: J Nutr Date: 2006-06 Impact factor: 4.798
Authors: Jorge J Janson; Carlos R Galarza; Alicia Murúa; Irene Quintana; Pablo A Przygoda; Gabriel Waisman; Luis Camera; Lucia Kordich; Margarita Morales; Luis M Mayorga; Mario I Camera Journal: Am J Hypertens Date: 2002-05 Impact factor: 2.689
Authors: Hong Wang; XiaoHua Jiang; Fan Yang; John W Gaubatz; Lang Ma; Mark J Magera; XiaoFeng Yang; Peter B Berger; William Durante; Henry J Pownall; Andrew I Schafer Journal: Blood Date: 2002-12-27 Impact factor: 22.113
Authors: Ye Chang; Yuan Li; Xiaofan Guo; Yintao Chen; Dongxue Dai; Yingxian Sun Journal: Int J Environ Res Public Health Date: 2017-04-03 Impact factor: 3.390
Authors: Augustine N Odili; Babangida S Chori; Benjamin Danladi; Peter C Nwakile; Innocent C Okoye; Umar Abdullahi; Maxwell N Nwegbu; Kefas Zawaya; Ime Essien; Kabiru Sada; John O Ogedengbe; Akinyemi Aje; Godsent C Isiguzo Journal: Glob Heart Date: 2020-07-10